Biotech News
Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
ir.syndax.com2026-05-06 14:52 EST
NEW YORK , Jan. 05, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger , Chief Executive Officer, will present at the 44th Annual J.P.